Is Wandercraft Atalante X actually deployed in the real world?

Yes. Wandercraft Atalante X is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.

Who makes Wandercraft Atalante X?

Wandercraft Atalante X is made by Wandercraft, based in Paris, France, founded in 2012.

Where is Wandercraft Atalante X deployed?

1 verified deployment of Wandercraft Atalante X is on the DEPLOY registry, including at Paris.

Can you buy Wandercraft Atalante X?

Wandercraft Atalante X is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.

Is Wandercraft Atalante X FDA cleared?

Wandercraft Atalante X has 1 regulatory record on the DEPLOY registry: FDA 510(k) clearance, cleared. See the Regulatory filings section for each agency source.

What are alternatives to Wandercraft Atalante X?

On the DEPLOY registry, comparable exoskeleton robots to Wandercraft Atalante X include German Bionic Cray X, Cyberdyne HAL, EksoNR, ReWalk 7.

How does Wandercraft Atalante X compare to German Bionic Cray X?

Wandercraft Atalante X and German Bionic Cray X (German Bionic · 5 deployments) are both exoskeleton robots on the DEPLOY registry. Wandercraft Atalante X has 1 verified deployment on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.

Is Wandercraft Atalante X a top exoskeleton?

On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Wandercraft Atalante X ranks in roughly the top 45% of exoskeleton models tracked by the registry.

What is Wandercraft Atalante X's maturity stage?

Wandercraft Atalante X is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.

Is Wandercraft Atalante X safe?

Wandercraft Atalante X has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.

Robot model

Wandercraft Atalante X

Powered, self-balancing full-body lower-limb exoskeleton that walks HANDS-FREE (no crutches) using AI-driven dynamic balance across ~12 actuated degrees of…

Manufacturer: Wandercraft
Form factor: exoskeleton
Maturity: commercial
Lifecycle: active
Deployments: 1

Overview

Powered, self-balancing full-body lower-limb exoskeleton that walks HANDS-FREE (no crutches) using AI-driven dynamic balance across ~12 actuated degrees of freedom. The autonomy is real-time balance/gait control; clinician sets the session. FDA cleared early 2024, indications expanded 2025 (MS, C4-L5 SCI). Deployed in 100+ rehab/research facilities.

Verified vs. claimed

Maturity stage: commercial(Commercially deployed with revenue-generating operations.)
Verified deployments: 1 deployment on file
Sources on file: 2 sources, view all

Key facts

Robot

Atalante is a self-balancing, hands-free walking exoskeleton that requires no crutches.

Technology

Uses AI-driven dynamic balance for walking.

Company type

French powered-exoskeleton maker

Specs

Use

medical rehab

Control

AI-driven autonomous dynamic balance (hands-free, no crutches)

Powered

yes (12 actuated DOF)

Regulatory

FDA cleared 2024, expanded 2025

Body region

full-body lower-limb

Availability

commercial (100+ facilities)

Data & sources

Web sources

2 sources backing this record.View all →

Pricing

No verified price is on record for Wandercraft Atalante X. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

How DEPLOY tracks pricing

Deployments (1)

Wandercraft Atalante X at Parisoperational
Wandercraft Atalante X self-balancing exoskeleton deployed at rehabilitation hospitals in Paris, France.

Wandercraft Atalante X on the deployment map

Where Wandercraft Atalante X is verified operating. Explore the deployment map by place and type.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Verified media addedVerifiedJun 11, 2026
Wandercraft Atalante X features demonstration
Record createdJun 6, 2026
Added to the verified registry

Full change history →

Regulatory filings (1)

fda_510kfda 510k · us_fdacleared

Safety record

No incidents on record for Wandercraft Atalante X.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (2)

Common questions

What is Wandercraft Atalante X?: Powered, self-balancing full-body lower-limb exoskeleton that walks HANDS-FREE (no crutches) using AI-driven dynamic balance across ~12 actuated degrees of freedom. The autonomy is real-time balance/gait control; clinician sets the session. FDA cleared early 2024, indications expanded 2025 (MS, C4-L5 SCI). Deployed in 100+ rehab/research facilities.
How much does Wandercraft Atalante X cost?: Wandercraft Atalante X's price is not publicly disclosed. DEPLOY has no verified price on record for Wandercraft Atalante X from Wandercraft. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is Wandercraft Atalante X actually deployed in the real world?: Yes. Wandercraft Atalante X is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes Wandercraft Atalante X?: Wandercraft Atalante X is made by Wandercraft, based in Paris, France, founded in 2012.
Where is Wandercraft Atalante X deployed?: 1 verified deployment of Wandercraft Atalante X is on the DEPLOY registry, including at Paris.
Can you buy Wandercraft Atalante X?: Wandercraft Atalante X is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
Is Wandercraft Atalante X FDA cleared?: Wandercraft Atalante X has 1 regulatory record on the DEPLOY registry: FDA 510(k) clearance, cleared. See the Regulatory filings section for each agency source.
What are alternatives to Wandercraft Atalante X?: On the DEPLOY registry, comparable exoskeleton robots to Wandercraft Atalante X include German Bionic Cray X, Cyberdyne HAL, EksoNR, ReWalk 7.
How does Wandercraft Atalante X compare to German Bionic Cray X?: Wandercraft Atalante X and German Bionic Cray X (German Bionic · 5 deployments) are both exoskeleton robots on the DEPLOY registry. Wandercraft Atalante X has 1 verified deployment on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is Wandercraft Atalante X a top exoskeleton?: On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Wandercraft Atalante X ranks in roughly the top 45% of exoskeleton models tracked by the registry.
What is Wandercraft Atalante X's maturity stage?: Wandercraft Atalante X is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
Is Wandercraft Atalante X safe?: Wandercraft Atalante X has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.

Methodology: Verified · 2 sources (no primary) · last reviewed 2026-07-08

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-07-08

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: exoskeleton

Sources by quality tier

1: unclassified; Unclassified source
1: knowledge-base; Knowledge base

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Recent coverage

Wandercraft Atalante X in third-party press

First patient enrolls in clinical trial for Wandercraft Atalante X exoskeleton - The Robot Report

Jan 30, 2026

Wandercraft Gains Second FDA Indication Extension for Atalante X in Less Than Two Years, Extending Advanced Robotic Rehabilitation for More Patients with Severe Mobility Loss - BioSpace

Nov 4, 2025

FDA expands indications for Wandercraft robotic exoskeleton - MassDevice

Nov 3, 2025

Wandercraft Atalante X

Overview

Key facts

Specs

Data & sources

Pricing

Deployments (1)

Wandercraft Atalante X on the deployment map

Recent activity

Regulatory filings (1)

Safety record

Sources (2)

Common questions

Recent coverage

In the press

First patient enrolls in clinical trial for Wandercraft Atalante X exoskeleton - The Robot Report

Wandercraft Gains Second FDA Indication Extension for Atalante X in Less Than Two Years, Extending Advanced Robotic Rehabilitation for More Patients with Severe Mobility Loss - BioSpace

FDA expands indications for Wandercraft robotic exoskeleton - MassDevice

Wandercraft raises $75m in funding to introduce self-balancing exoskeleton - Medical Device Network

Exoskeleton maker Wandercraft raises $75M alongside Renault partnership - Fierce Biotech

French Wandercraft raises €64.3 million to take robotics from hospitals to homes and factory floors - EU-Startups

Wandercraft Atalante X exoskeleton improves woman's walking ability seven years after stroke - Notebookcheck

Paralyzed Kevin Piette walks with Olympics 2024 torch while wearing Wandercraft Atalante X exoskeleton - Notebookcheck

Wandercraft exoskeleton used in Olympic torch relay - The Robot Report

Groundbreaking Wandercraft Personal Exoskeleton enables wheelchair-bound, paralyzed people to walk again - Notebookcheck

Wandercraft gets second FDA nod for self-balancing exoskeleton - BioWorld News

Wandercraft tacks on 2nd FDA nod for self-balancing exoskeleton suit - Fierce Biotech

Machine-readable surfaces

Wandercraft Atalante X

Overview

Key facts

Specs

Data & sources

Pricing

Deployments (1)

Wandercraft Atalante X on the deployment map

Recent activity

Regulatory filings (1)

Safety record

Sources (2)

Common questions

Recent coverage

Related exoskeleton

In the press

First patient enrolls in clinical trial for Wandercraft Atalante X exoskeleton - The Robot Report

Wandercraft Gains Second FDA Indication Extension for Atalante X in Less Than Two Years, Extending Advanced Robotic Rehabilitation for More Patients with Severe Mobility Loss - BioSpace

FDA expands indications for Wandercraft robotic exoskeleton - MassDevice

Wandercraft raises $75m in funding to introduce self-balancing exoskeleton - Medical Device Network

Exoskeleton maker Wandercraft raises $75M alongside Renault partnership - Fierce Biotech

French Wandercraft raises €64.3 million to take robotics from hospitals to homes and factory floors - EU-Startups

Wandercraft Atalante X exoskeleton improves woman's walking ability seven years after stroke - Notebookcheck

Paralyzed Kevin Piette walks with Olympics 2024 torch while wearing Wandercraft Atalante X exoskeleton - Notebookcheck

Wandercraft exoskeleton used in Olympic torch relay - The Robot Report

Groundbreaking Wandercraft Personal Exoskeleton enables wheelchair-bound, paralyzed people to walk again - Notebookcheck

Wandercraft gets second FDA nod for self-balancing exoskeleton - BioWorld News

Wandercraft tacks on 2nd FDA nod for self-balancing exoskeleton suit - Fierce Biotech

Machine-readable surfaces